Table 4.
Baseline characteristics of the validation cohort (n[%]; mean ± SD; median [Q1–Q3]).
| Baseline characteristics | Validation cohort (n = 137) | Mortality | |
|---|---|---|---|
| Survived (n = 110) | Deceased (n = 27) | ||
| Anosmia/hyposmia | 25 (18.2) | 22 (20.0) | 3 (11.1) |
| Dyspnoea | 79 (57.7) | 57 (51.8) | 22 (81.5) |
| Loss of consciousness | 12 (8.8) | 3 (2.7) | 9 (33.3) |
| Mean arterial pressure, mmHg | 95.09 ± 15.09 | 96.40 ± 13.63 | 89.73 ± 19.37 |
| Peripheral oxygen saturation, % | 97.00 (92.00–98.00) | 97.00 (93.75–98.00) | 95.00 (85.00–98.00) |
| Neutrophil, % | 72.15 ± 13.65 | 70.39 ± 13.29 | 79.34 ± 12.94 |
| Serum urea, mg/dL | 25.60 (17.70–44.85) | 24.50 (17.38–36.75) | 47.70 (24.40–120.60) |
| Affected lung area score, % | 8.0 (1.0–26.5) | 7.0 (1.0–20) | 31.0 (2.0–45.0) |
Categorical data are summarized using frequencies and percentages n (%). Continuous data are presented either as mean values with standard deviation (mean ± SD) for normally distributed data, or as median values with the first and third quartiles [median (Q1–Q3)] for data that are not normally distributed.